Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 216 entries
View as:

A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)

Phase: N/A Priority: Normal
NCT ID: NCT01302587 Org: User:
Start: 03/31/11 End: 06/30/11 Due: 06/30/12

Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT01747629 Org: User:
Start: 12/31/12 End: 11/30/13 Due: 11/30/14

To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125

Phase: N/A Priority: Normal
NCT ID: NCT02673567 Org: User:
Start: 03/31/16 End: 02/10/17 Due: 02/10/18

A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01047319 Org: User:
Start: 05/27/10 End: 06/30/17 Due: 06/30/18

Absolute Bioavailability of Reslizumab in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01990443 Org: User:
Start: 06/30/13 End: 03/31/14 Due: 03/31/15

Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT01811576 Org: User:
Start: 03/31/13 End: 08/05/13 Due: 08/05/14

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01424813 Org: User:
Start: 12/31/12 End: 11/30/13 Due: 11/30/14

Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

Phase: N/A Priority: Normal
NCT ID: NCT01307319 Org: User:
Start: 03/31/11 End: 08/31/11 Due: 08/31/12

Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique

Phase: N/A Priority: Normal
NCT ID: NCT00054964 Org: User:
Start: 03/31/03 End: 08/31/03 Due: 08/31/04

Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01632540 Org: User:
Start: 07/31/12 End: 02/28/14 Due: 02/28/15

A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus

Phase: N/A Priority: Normal
NCT ID: NCT00203151 Org: User:
Start: 07/31/05 End: 02/28/07 Due: 02/28/08

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT01899144 Org: User:
Start: 07/31/13 End: 10/31/13 Due: 10/31/14

Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT00109668 Org: User:
Start: 07/31/04 End: 09/30/06 Due: 09/30/07

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT02437604 Org: User:
Start: 05/31/15 End: 09/30/15 Due: 09/30/16

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

Phase: N/A Priority: Normal
NCT ID: NCT00203112 Org: User:
Start: 06/30/04 End: 07/31/06 Due: 07/31/07

Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03029000 Org: User:
Start: 08/02/17 End: 10/30/17 Due: 10/30/18

Azilect + Antidepressant Chart Review

Phase: N/A Priority: Normal
NCT ID: NCT00955604 Org: User:
Start: 07/31/09 End: 06/30/10 Due: 06/30/11

Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).

Phase: N/A Priority: Normal
NCT ID: NCT00337779 Org: User:
Start: 08/31/06 End: 10/31/08 Due: 10/31/09

Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT03567291 Org: User:
Start: 05/25/18 End: 05/15/20 Due: 05/15/21

Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness

Phase: N/A Priority: Normal
NCT ID: NCT00203021 Org: User:
Start: 03/26/94 End: 02/28/18 Due: 02/28/19

Adenovirus Vaccine Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT01584037 Org: User:
Start: 12/31/11 End: 04/30/14 Due: 04/30/15

A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05668013 Org: User:
Start: 01/11/23 End: 03/08/31 Due: 03/08/32

Assessment of LBR-101 In Chronic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT02021773 Org: User:
Start: 01/31/14 End: 03/31/15 Due: 03/31/16

A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04041284 Org: User:
Start: 09/13/19 End: 08/31/22 Due: 08/31/23

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT01085097 Org: User:
Start: 09/01/10 End: 10/24/12 Due: 10/24/13